Primary Record
Darolutamide
- In stock
- 7,633 g
- Purity
- 98.1 %
- CAS
- 1297538-32-9
Compound Identifiers & Properties
- CAS
- 1297538-32-9
- PubChem CID
- 67171867
- SMILES
- C[C@@H](CN1C=CC(=N1)C2=CC(=C(C=C2)C#N)Cl)NC(=O)C3=NNC(=C3)C(C)O
- Canonical SMILES
- CC(O)c1cc(C(=O)N[C@@H](C)Cn2ccc(-c3ccc(C#N)c(Cl)c3)n2)n[nH]1
Names & Synonyms
- Darolutamide
- Nubeqa
- ODM-201
- darolutamida
- 1297538-32-9
- darolutamidum
- Darolutamide [USAN]
- Nebeqa (TN)
- BAY1841788
- X05U0N2RCO
- Darolutamide (Standard)
- Antiandrogen ODM-201
- BAY-1841788
- RefChem:58141
- Darolutamide (ODM-201)
- DAROLUTAMIDE [MI]
- C19H19ClN6O2
- DAROLUTAMIDE [INN]
- DAROLUTAMIDE [JAN]
- UNII-X05U0N2RCO
- ODM-201(Darolutamide)?
- ODM201
- MFCD29472270
- DAROLUTAMIDE [WHO-DD]
- BAY 1841788
- Darolutamide (JAN/USAN/INN)
- DTXSID101027953
- orb1300350
- SCHEMBL1814935
- CHEMBL4297185
- SCHEMBL13733117
- SCHEMBL29390245
- GTPL10439
- KS-00000TSX
- EX-A759
- L02BB06
- ODM 201
- BLIJXOOIHRSQRB-PXYINDEMSA-N
- BDBM309979
- DAROLUTAMIDE [ORANGE BOOK]
- DTXCID001513521
- GLXC-90544
- 3-butyl-9H-pyrido[3,4-b]indole
- example 56 [US9657003]
- BDBM50556205
- EBC-17092
- HY-16985R
- NSC825331
- ORM-16497
- ORM-16555
- AKOS030526387
- ODM-201;BAY-1841788
- CCG-268640
- CS-1565
- CS-5174
- DB12941
- NSC-825331
- N-((S)-1-(3-(3-Chloro-4-cyanophenyl)-1H-pyrazol-1-yl)propan-2-yl)-5-(1-hydroxyethyl)-1H-pyrazole-3-carboxamide
- NCGC00484078-01
- AC-32628
- AS-75032
- BAY-1841788)
- CID:67171867
- DA-56387
- FD161413
- HY-16985
- SY242124
- SID:504700667
- S7559
- J3.501.129C
- D11045
- US9657003, 56
- A888821
- 1H-Pyrazole-3-carboxamide, N-[(1S)-2-[3-(3-chloro-4-cyanophenyl)-1H-pyrazol-1-yl]-1-methylethyl]-5-(1-hydroxyethyl)-
- BRD-A44971162-001-01-9
- Q25091391
- C000607739
- Z2512157889
- B0084-470833
- 1H-Pyrazole-3-carboxamide, N-((1S)-2-(3-(3-chloro-4-cyanophenyl)-1H-pyrazol-1-yl)-1-methylethyl)-5-(1-hydroxyethyl)-
- N-[(2S)-1-[3-(3-chloro-4-cyanophenyl)-1H-pyrazol-1-yl]propan-2-yl]-5-(1-hydroxyethyl)-1H-pyrazole-3-carboxamide
- N-[(2S)-1-[3-(3-chloro-4-cyanophenyl)pyrazol-1-yl]propan-2-yl]-5-(1-hydroxyethyl)-1H-pyrazole-3-carboxamide
- N-((2S)-1-(3-(3-chloro-4-cyanophenyl)-1H-pyrazol-1-yl)propan-2-yl)-5-((1RS)-1-hydroxyethyl)-1H-pyrazole-3-carboxamide
- N-((S)-1-(3-(3-chloro-4-cyanophenyl)-1H-pyrazol-1-yl)-propan-2-yl)-3-(1-hydroxyethyl)-1H-pyrazole-5-carboxamide
- N-[(1S)-2-[3-(3-chloro-4-cyano-phenyl)pyrazol-1-yl]-1-methyl-ethyl]-5-(1-hydroxyethyl)-1H-pyrazole-3-carboxamide
- 129756-97-4
- N-((1S)-2-(3-(3-Chloro-4-cyanophenyl)-1H-pyrazol-1-yl)-1-methylethyl)-5-(1-hydroxyethyl)-1H-pyrazole-3-carboxamide
- N-((2S)-1-(3-(3-CHLORO-4-CYANOPHENYL)-1H-PYRAZOL- 1-YL)PROPAN-2-YL)-5-((1RS)-1-HYDROXYETHYL)-1H-PYRAZOLE- 3-CARBOXAMIDE
- N-((2S)-1-(3-(3-chloro-4-cyanophenyl)-1H-pyrazol-1-yl)propan-2-yl)-5-(1-hydroxyethyl)-1H-pyrazole-3-carboxamide
- N-((2S)-1-(3-(3-chloro-4-cyanophenyl)pyrazol-1-yl)propan-2-yl)-5-(1-hydroxyethyl)-1H-pyrazole-3-carboxamide
- N-((S)-1-(3-(3-chloro-4-cyanophenyl)-1H-pyrazol -1-yl)propan-2-yl)-3-(1-hydroxyethyl)-1H-pyrazole-5-carboxamide
- N-((S)-1-(3-(3-chloro-4-cyanophenyl)-1H-pyrazol-1-yl)propan-2-yl)-3-(1-hydroxyethyl)-1H-pyrazole-5-carboxamide
- N-((S)-1-(3-(3-Chloro-4-cyanophenyl)-1H-pyrazol-1-yl)propan-2-yl)-5-(1-hydroxy-ethyl)-1H-pyrazole-3-carboxamide
- N-[(1S)-2-[3-(3-Chloro-4-cyanophenyl)-1H-pyrazol-1-yl]-1-methylethyl]-5-(1-hydroxyethyl)-1H-pyrazole-3-carboxamide
- N-[(1S)-2-[3-(3-Chloro-4-cyanophenyl)-1H-pyrazol-1-yl]-1-methylethyl]-5-(1-hydroxyethyl)-1H-pyrazole-3-carboxamide; BAY 1841788; ODM-201
- N-[(2S)-1-[3-(3-chloro-4-cyanophenyl)pyrazol-1-yl]propan-2-yl]-5-(1-hydroxyethyl)-2H-pyrazole-3-carboxamide
- N-[(S)-1-(3-(3-Chloro-4-cyanophenyl)-1H-pyrazole-1-yl)propane-2-yl]-5-(1-hydroxyethyl)-1H-pyrazole-3-carboxamide
- N-[(S)-1-[3-(3-Chloro-4-cyanophenyl)-1-pyrazolyl]-2-propyl]-5-(1-hydroxyethyl)pyrazole-3-carboxamide
- N-[(S)-1-[3-(3-Chloro-4-cyanophenyl)-1H-pyrazole-1-yl]propane-2-yl]-5-(1-hydroxyethyl)-1H-pyrazole-3-carboxamide